90Y Ibritumomab Tiuxetan
Abstract
Am J Cancer 2002; 1 (5): 349 GUEST COMMENTARIES 1175-6357/02/0005-0349/$25.00/0 © Adis International Limited. All rights reserved. coated CD20+ cells. However, although Y does not emit γ Y Ibritumomab Tiuxetan A Viewpoint by Nozomi Niitsu radiation, therefore, making radiation exposure to healthcare per- sonnel minimal, a multidisciplinary team approach is needed to Kitasato University School of Medicine, Kitasato, Sagamihara, Kanagawa, Japan safely and effectively provide...